CR11761A - Proceso para la preparacion de sulfamatos de heteroarilo benzofusionado y la forma cristalina de n-(((2s)-6-cloro-2,3-dihidro-1,4-benzodioxin-2il)metil-sulfamida - Google Patents
Proceso para la preparacion de sulfamatos de heteroarilo benzofusionado y la forma cristalina de n-(((2s)-6-cloro-2,3-dihidro-1,4-benzodioxin-2il)metil-sulfamidaInfo
- Publication number
- CR11761A CR11761A CR11761A CR11761A CR11761A CR 11761 A CR11761 A CR 11761A CR 11761 A CR11761 A CR 11761A CR 11761 A CR11761 A CR 11761A CR 11761 A CR11761 A CR 11761A
- Authority
- CR
- Costa Rica
- Prior art keywords
- sulfamates
- preparation
- benzofused
- heteroarilo
- benzodioxin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/04—Seven-membered rings not condensed with other rings
- C07D321/08—1,4-Dioxepines; Hydrogenated 1,4-dioxepines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se dirige a un proceso para la preparación de sulfamatos de heteroarilo benzofusionados, útiles para el tratamiento de epilepsia y transtonos relacionados.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2008/058233 WO2009120191A1 (en) | 2008-03-26 | 2008-03-26 | Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11761A true CR11761A (es) | 2011-07-06 |
Family
ID=40030223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11761A CR11761A (es) | 2008-03-26 | 2010-10-26 | Proceso para la preparacion de sulfamatos de heteroarilo benzofusionado y la forma cristalina de n-(((2s)-6-cloro-2,3-dihidro-1,4-benzodioxin-2il)metil-sulfamida |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP2280950A1 (es) |
JP (1) | JP2011515464A (es) |
KR (1) | KR20100126535A (es) |
CN (1) | CN101981019A (es) |
AU (1) | AU2008353491A1 (es) |
BR (1) | BRPI0822454A2 (es) |
CA (1) | CA2719624A1 (es) |
CR (1) | CR11761A (es) |
EA (1) | EA201071120A1 (es) |
EC (1) | ECSP10010499A (es) |
IL (1) | IL208222A0 (es) |
MX (1) | MX2010010595A (es) |
WO (1) | WO2009120191A1 (es) |
ZA (1) | ZA201007611B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
JP2008545650A (ja) | 2005-05-20 | 2008-12-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | スルファミド誘導体の製造方法 |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
TW200812573A (en) | 2006-05-19 | 2008-03-16 | Janssen Pharmaceutica Nv | Co-therapy for the treatment of epilepsy and related disorders |
MX2011000090A (es) * | 2008-06-23 | 2011-03-02 | Janssen Pharmaceutica Nv | Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]diox in-2-ilmetil)sulfamida. |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
CN107954906B (zh) * | 2017-11-24 | 2020-10-16 | 西北师范大学 | 一种芳基磺酰叔胺类化合物的合成方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
TW200612905A (en) * | 2004-06-16 | 2006-05-01 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
MY147767A (en) * | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
MX2007002309A (es) * | 2004-08-24 | 2007-10-08 | Johnson & Johnson | Novedosos derivados de heteroarilsulfamida benzofusionados utiles como agentes anticonvulsivos. |
TW200738669A (en) * | 2006-02-22 | 2007-10-16 | Janssen Pharmaceutica Nv | Crystalline forms of N-(benzo[b]thien-3-ylmethyl)-sulfamide |
-
2008
- 2008-03-26 EP EP08744381A patent/EP2280950A1/en not_active Withdrawn
- 2008-03-26 MX MX2010010595A patent/MX2010010595A/es unknown
- 2008-03-26 JP JP2011501761A patent/JP2011515464A/ja not_active Withdrawn
- 2008-03-26 EA EA201071120A patent/EA201071120A1/ru unknown
- 2008-03-26 CA CA2719624A patent/CA2719624A1/en not_active Abandoned
- 2008-03-26 KR KR1020107023447A patent/KR20100126535A/ko not_active Application Discontinuation
- 2008-03-26 CN CN2008801285434A patent/CN101981019A/zh active Pending
- 2008-03-26 AU AU2008353491A patent/AU2008353491A1/en not_active Abandoned
- 2008-03-26 WO PCT/US2008/058233 patent/WO2009120191A1/en active Application Filing
- 2008-03-26 BR BRPI0822454-4A patent/BRPI0822454A2/pt not_active IP Right Cessation
-
2010
- 2010-09-19 IL IL208222A patent/IL208222A0/en unknown
- 2010-09-24 EC EC2010010499A patent/ECSP10010499A/es unknown
- 2010-10-25 ZA ZA2010/07611A patent/ZA201007611B/en unknown
- 2010-10-26 CR CR11761A patent/CR11761A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101981019A (zh) | 2011-02-23 |
KR20100126535A (ko) | 2010-12-01 |
AU2008353491A1 (en) | 2009-10-01 |
EA201071120A1 (ru) | 2011-06-30 |
WO2009120191A1 (en) | 2009-10-01 |
IL208222A0 (en) | 2010-12-30 |
CA2719624A1 (en) | 2009-10-01 |
BRPI0822454A2 (pt) | 2015-06-16 |
ZA201007611B (en) | 2012-04-25 |
ECSP10010499A (es) | 2010-10-30 |
MX2010010595A (es) | 2010-10-25 |
JP2011515464A (ja) | 2011-05-19 |
EP2280950A1 (en) | 2011-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR11761A (es) | Proceso para la preparacion de sulfamatos de heteroarilo benzofusionado y la forma cristalina de n-(((2s)-6-cloro-2,3-dihidro-1,4-benzodioxin-2il)metil-sulfamida | |
ECSP10010498A (es) | Procesos para la preparación de derivados de heteroarilo benzofusionados | |
BRPI0821688A2 (pt) | mistura para o tratamento de fertilizantes contendo uréia | |
DOP2012000263A (es) | Compuestos quimicos | |
DOP2013000118A (es) | Compuesto bicíclico | |
BRPI0923325A2 (pt) | métodos para usar um composto, e para suprimir a produção deum composto de isocianato livre. | |
MX2010007490A (es) | Preparacion de derivados de sulfamida. | |
EA201170356A1 (ru) | Полиморфные и аморфные формы лакозамида и аморфные композиции | |
DE602008003911D1 (de) | Co-kristalle von propiconazol | |
BR112012004411A2 (pt) | processo para a preparação de borracha de nitrila hidrogenada | |
CR20160465A (es) | Polimorfo b de la n-(2-aminofenil)-4-[n-(piridin-3-il) metoxicarbonilamino-metil] benzamida (ms-275) | |
AR058253A1 (es) | Procedimiento para la preparacion de ferri-succinilcaseina | |
CL2012001031A1 (es) | Compuestos derivados de 2-oxo-1-pirrolidinil-imidazotiadiazol; composición farmacéutica que los comprende; útiles para el tratamiento de la epilepsia, transtornos neurológicos, entre otros. | |
DE112010000867T8 (de) | Herstellungsverfahren für SiC-Einkristall vom n-Typ, dadurch erhaltener SiC-Einkristall vom n-Typ und dessen Anwendung | |
CU23820A3 (es) | (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y procedimiento de obtención | |
CL2011001405A1 (es) | Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina. | |
UY32716A (es) | Compuestos de pirazina carboxamida útiles para el tratamiento de diabetes y obesidad | |
CL2008002532A1 (es) | Procedimiento de sintesis de un derivado de pirido-[2,1-a]isoquinolina; formas cristalinas de dichos compuestos; y su uso para tratar diabetes, diabetes mellitus, trastorno de la intolerancia a la glucosa. | |
BR112013021882A2 (pt) | síntese de compostos orgânicos | |
EA201200740A1 (ru) | Способ пиролиза углеводов | |
PA8798401A1 (es) | Forma cristalina 1 de 2-((r)-2-metilpirrolidin-2-il)-1h-benzimidazol-4-carboxamida | |
EA201170481A1 (ru) | Сокристаллы | |
ECSP13012459A (es) | Valsartan altamente cristalino | |
GT200900215A (es) | Nuevo procedimiento de obtencion de la forma cristalina v de la agomelatina. | |
BRPI1007718A2 (pt) | processo para a produção de cristais de cianeto de sódio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |